|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-3-26
|
|
pubmed:abstractText |
To retrospectively compare the biochemical disease-free survival (BDFS) of patients treated with standard dose external beam radiotherapy (SD-EBRT), SD-EBRT plus androgen deprivation (AD), and brachytherapy-based treatment (brachytherapy with or without EBRT with or without AD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1527-9995
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
541-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17382161-Androgen Antagonists,
pubmed-meshheading:17382161-Brachytherapy,
pubmed-meshheading:17382161-Combined Modality Therapy,
pubmed-meshheading:17382161-Disease-Free Survival,
pubmed-meshheading:17382161-Humans,
pubmed-meshheading:17382161-Male,
pubmed-meshheading:17382161-Multivariate Analysis,
pubmed-meshheading:17382161-Prognosis,
pubmed-meshheading:17382161-Prostate-Specific Antigen,
pubmed-meshheading:17382161-Prostatic Neoplasms,
pubmed-meshheading:17382161-Retrospective Studies
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Columbia University College of Physicians and Surgeons, New York, New York, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
